• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comments Regarding: "Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study".

作者信息

Vasigh Mahtab, Greer Jonathan B, Nicolson Norman G

机构信息

Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.

Department of Surgery, School of Medicine, The Johns Hopkins University, Baltimore, USA.

出版信息

Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-18047-5.

DOI:10.1245/s10434-025-18047-5
PMID:40767938
Abstract
摘要

相似文献

1
Comments Regarding: "Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study".关于《胃腺癌细胞减灭术联合腹腔热灌注化疗的生存结局：一项国家癌症数据库研究》的评论
Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-18047-5.
2
Survival outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in selected patients with stage IV gastric adenocarcinoma - A Canadian case series.特定IV期胃腺癌患者的细胞减灭术及腹腔内热灌注化疗的生存结局——一项加拿大病例系列研究
Eur J Surg Oncol. 2025 Aug;51(8):110000. doi: 10.1016/j.ejso.2025.110000. Epub 2025 Apr 3.
3
The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: where do we stand today? A comprehensive review and clinical insights from a leading oncology center in India.完全细胞减灭术联合腹腔热灌注化疗在卵巢癌中的作用：我们如今处于什么阶段？来自印度一家领先肿瘤中心的全面综述与临床见解。
World J Surg Oncol. 2025 Jun 11;23(1):232. doi: 10.1186/s12957-025-03869-0.
4
Heated IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent Ovarian Cancer: A Systematic Literature Review.复发性卵巢癌患者的热灌注化疗（HIPEC）：系统文献综述
Int J Gynecol Cancer. 2016 May;26(4):661-70. doi: 10.1097/IGC.0000000000000664.
5
The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.30年经验——热腹腔内化疗治疗胃癌的随机及高质量非随机研究的荟萃分析
Eur J Cancer. 2017 Jul;79:1-14. doi: 10.1016/j.ejca.2017.03.030. Epub 2017 Apr 26.
6
Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.细胞减灭术和腹腔热灌注化疗联合结直肠癌肝转移灶治愈性治疗的腹膜转移：所有文献的系统评价和观察性研究的荟萃分析。
Cancer Treat Rev. 2013 Jun;39(4):321-7. doi: 10.1016/j.ctrv.2012.11.003. Epub 2012 Dec 12.
7
Postoperative leukopenia after cytoreductive surgery and hypertherm intraperitoneal chemotherapy for colorectal carcinomatosis- causes and implication on outcomes in a population-based study.减瘤手术联合腹腔内热化疗治疗结直肠癌肝转移术后白细胞减少症——一项基于人群研究中的病因及对预后的影响
World J Surg Oncol. 2025 Apr 29;23(1):173. doi: 10.1186/s12957-025-03821-2.
8
Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?阑尾腺癌中的突变特征：热腹腔内化疗未来个性化的潜力？
Per Med. 2025 Jul 11:1-8. doi: 10.1080/17410541.2025.2532360.
9
Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study.胃腺癌行细胞减灭术联合 HIPEC 的生存结局：国家癌症数据库研究。
Ann Surg Oncol. 2024 Dec;31(13):8549-8559. doi: 10.1245/s10434-024-16142-7. Epub 2024 Sep 5.
10
Interval Cytoreductive Surgery and Cisplatin- or Paclitaxel-Based HIPEC for Advanced Ovarian Cancer.间隔性细胞减灭术及基于顺铂或紫杉醇的腹腔热灌注化疗治疗晚期卵巢癌
JAMA Netw Open. 2025 Jun 2;8(6):e2517676. doi: 10.1001/jamanetworkopen.2025.17676.

本文引用的文献

1
Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study.胃腺癌行细胞减灭术联合 HIPEC 的生存结局：国家癌症数据库研究。
Ann Surg Oncol. 2024 Dec;31(13):8549-8559. doi: 10.1245/s10434-024-16142-7. Epub 2024 Sep 5.
2
The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.时机、治疗、问题：以手术肿瘤学为例，使用流行病学方法最小化真实世界数据中不朽时间偏倚的比较。
Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2079-2086. doi: 10.1158/1055-9965.EPI-22-0495.
3
Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease.
胃癌伴腹膜疾病行细胞减灭术和 HIPEC 的现状。
J Surg Oncol. 2022 Jun;125(7):1176-1182. doi: 10.1002/jso.26894.
4
Understanding and identifying immortal-time bias in surgical health services research: An example using surgical resection of stage IV breast cancer.理解和识别外科医疗服务研究中的不朽时间偏倚：以IV期乳腺癌手术切除为例。
Surg Oncol. 2021 Jun;37:101539. doi: 10.1016/j.suronc.2021.101539. Epub 2021 Mar 5.
5
Survival Analysis and the Immortal Time Bias.生存分析与不朽时间偏倚
JAMA Ophthalmol. 2018 Nov 1;136(11):1314-1315. doi: 10.1001/jamaophthalmol.2018.3499.
6
Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database.事件发生时间结局观察性研究中的不朽时间偏倚：利用国家癌症数据库评估乳房切除术后放射治疗的效果
Cancer Control. 2018 Jan-Dec;25(1):1073274818789355. doi: 10.1177/1073274818789355.